在腹腔大动脉动脉瘤扩张和破裂中,CCR2/CCL2分子轴的调节
Ryan Wahidi1,2, Santiago Elizondo-Benedetto1, Ryan Catlett1
1Division of Vascular Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO, United States.
Frontiers in cardiovascular medicine
|March 5, 2026
概括
准CCR2/CCL2通路可以减少腹腔大动脉瘤 (AAA) 的进展. 在临床环境中,CCR2抑制显示出对管理AAA扩张和破裂风险的希望.
科学领域:
- 心血管生物学 心血管生物学
- 免疫学 免疫学 免疫学
- 血管医学 血管医学
背景情况:
- CCR2/CCL2分子轴是腹腔大动脉动脉瘤 (AAA) 发病过程中不可或缺的组成部分.
- 这一途径驱动炎症,细胞外基质降解和通过免疫细胞招募进行血管重塑.
研究的目的:
- 审查CCR2/CCL2在AAA中的作用.
- 强调CCR2抑制作为AAA管理的治疗策略.
主要方法:
- 对动物模型中CCR2抑制的临床前研究的审查.
- 分析新兴的成像技术,在人类AAA中验证CCR2.
- 评估正在进行的临床试验和翻译研究.
主要成果:
- 临床前研究表明,抑制CCR2可以减少AAA的形成,扩张和进展.
- 在人类中,CCR2已被验证为AAA不稳定的生物标志物.
- CCR2封锁是减轻AAA扩张和断裂风险的一个有希望的策略.
结论:
- 针对CCR2的干预措施为AAA管理提供了潜在的解决方案.
- 对于长线AAA护理,CCR2阻断的进一步临床开发是有必要的.
相关概念视频
Aneurysm III: Interprofessional Care
414
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
414
Aneurysm II: Clinical Manifestations and Diagnostic Studies
449
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
449
Aneurysm I: Introduction
562
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
562
Aortic Regurgitation I: Introduction
955
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
955
Aortic Regurgitation III: Medical Management
525
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
525


